Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 4
2006 1
2010 1
2011 1
2014 1
2016 1
2017 2
2018 1
2019 1
2021 1
2022 5
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Metronomic Chemotherapy.
Cazzaniga ME, Cordani N, Capici S, Cogliati V, Riva F, Cerrito MG. Cazzaniga ME, et al. Among authors: cordani n. Cancers (Basel). 2021 May 6;13(9):2236. doi: 10.3390/cancers13092236. Cancers (Basel). 2021. PMID: 34066606 Free PMC article. Review.
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons.
Cortinovis DL, Colonese F, Abbate MI, Sala L, Meazza Prina M, Cordani N, Sala E, Canova S. Cortinovis DL, et al. Among authors: cordani n. Front Med (Lausanne). 2022 Dec 1;9:989405. doi: 10.3389/fmed.2022.989405. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36530878 Free PMC article. Review.
Chronic myeloid leukemia: Second-line drugs of choice.
Gambacorti-Passerini C, Aroldi A, Cordani N, Piazza R. Gambacorti-Passerini C, et al. Among authors: cordani n. Am J Hematol. 2016 Jan;91(1):67-75. doi: 10.1002/ajh.24247. Am J Hematol. 2016. PMID: 26588811 Free article. Review.
Edaravone: A Novel Possible Drug for Cancer Treatment?
Duranti E, Cordani N, Villa C. Duranti E, et al. Among authors: cordani n. Int J Mol Sci. 2024 Jan 29;25(3):1633. doi: 10.3390/ijms25031633. Int J Mol Sci. 2024. PMID: 38338912 Free PMC article. Review.
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC).
Cordani N, Lisini D, Coccè V, Paglia G, Meanti R, Cerrito MG, Tettamanti P, Bonaffini L, Paino F, Alessandri G, Marcianti A, Giannì A, Villa C, Mauri M, Mologni L, Torsello A, Pessina A, Cazzaniga ME. Cordani N, et al. Int J Mol Sci. 2023 Mar 20;24(6):5864. doi: 10.3390/ijms24065864. Int J Mol Sci. 2023. PMID: 36982938 Free PMC article.
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation.
Scagliotti A, Capizzi L, Cazzaniga ME, Ilari A, De Giorgi M, Cordani N, Gallazzi M, Bruno A, Pelosi G, Albini A, Lavitrano M, Grassilli E, Cerrito MG. Scagliotti A, et al. Among authors: cordani n. Front Oncol. 2022 Nov 30;12:998274. doi: 10.3389/fonc.2022.998274. eCollection 2022. Front Oncol. 2022. PMID: 36531071 Free PMC article.
27 results